Forrest Sheng Bao
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Forrest Sheng Bao has a total of 87 co-authors. Here are the top co-authors by number of shared publications:
- Baoli Zhu
School of Public Health, Nanjing Medical University, Nanjing 211166, China
5 shared publications - Jie Liu
Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
5 shared publications - Lei Han
Nanjing Medical University
5 shared publications - Liu Ouyang
Department of Orthopaedics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China
5 shared publications - Shi Chen
University of North Carolina at Charlotte
5 shared publications - Yaorong Ge
Department of Software and Information Systems, College of Computing and Informatics, University of North Carolina at Charlotte, Charlotte, NC 28223, USA
5 shared publications
Latest Publications
- Open Access
- 1 January 2025
- Published by Association for Computational Linguistics (ACL)
- p. 799-811
Benchmarking LLM Faithfulness in RAG with Evolving Leaderboards
Manveer Singh Tamber, Forrest Sheng Bao, Chenyu Xu, Ge Luo, Suleman Kazi, Minseok Bae, Miaoran Li, Ofer Mendelevitch, Renyi Qu, Jimmy Lin. Proceedings of the 2025 Conference on Empirical Methods in Natural Language Processing: Industry Track. 2025.
- 1 January 2025
- Published by Association for Computational Linguistics (ACL)
- p. 799-811
Open AccessBenchmarking LLM Faithfulness in RAG with Evolving Leaderboards
Manveer Singh Tamber, Forrest Sheng Bao, Chenyu Xu, Ge Luo, Suleman Kazi, Minseok Bae, Miaoran Li, Ofer Mendelevitch, Renyi Qu, Jimmy Lin. Proceedings of the 2025 Conference on Empirical Methods in Natural Language Processing: Industry Track. 2025.
- Open Access
- 10 July 2024
- Published by NumFOCUS - Insight Software Consortium (ITK)
- p. 174-195
Funix - The laziest way to build GUI apps in Python
The rise of machine learning (ML) and artificial intelligence (AI), especially the generative AI (GenAI), has increased the need for wrapping models or algorithms into GUI apps. For example, a large language model (LLM) can be accessed through a string-to-string GUI app with a textbox as the primary input. Most of existing solutions require developers to manually create widgets and link them to arguments/returns of a function individually. This low-level process is laborious and usually intrusive. Funix automatically selects widgets based on the types of the arguments and returns of a function according to the type-to-widget mapping defined in a theme, e.g., bool to a checkbox. Consequently, an existing Python function can be turned into a GUI app without any code changes. As a transcompiler, Funix allows type-to-widget mappings to be defined between any Python type and any React component and its props, liberating Python developers to the frontend world without needing to know JavaScript/TypeScript. Funix further leverages features in Python or its ecosystem for building apps in a more Pythonic, intuitive, and effortless manner. With Funix, a developer can make it (a functional app) before they (competitors) fake it (in Figma or on a napkin).
- 10 July 2024
- Published by NumFOCUS - Insight Software Consortium (ITK)
- p. 174-195
Open AccessFunix - The laziest way to build GUI apps in Python
The rise of machine learning (ML) and artificial intelligence (AI), especially the generative AI (GenAI), has increased the need for wrapping models or algorithms into GUI apps. For example, a large language model (LLM) can be accessed through a string-to-string GUI app with a textbox as the primary input. Most of existing solutions require developers to manually create widgets and link them to arguments/returns of a function individually. This low-level process is laborious and usually intrusive. Funix automatically selects widgets based on the types of the arguments and returns of a function according to the type-to-widget mapping defined in a theme, e.g., bool to a checkbox. Consequently, an existing Python function can be turned into a GUI app without any code changes. As a transcompiler, Funix allows type-to-widget mappings to be defined between any Python type and any React component and its props, liberating Python developers to the frontend world without needing to know JavaScript/TypeScript. Funix further leverages features in Python or its ecosystem for building apps in a more Pythonic, intuitive, and effortless manner. With Funix, a developer can make it (a functional app) before they (competitors) fake it (in Figma or on a napkin).
- Open Access
DocAsRef: An Empirical Study on Repurposing Reference-Based Summary Quality Metrics Reference-Freely
Automated summary quality assessment falls into two categories: reference-based and reference-free. Reference-based metrics, historically deemed more accurate due to the additional information provided by human-written references, are limited by their reliance on human input. In this paper, we hypothesize that the comparison methodologies used by some reference-based metrics to evaluate a system summary against its corresponding reference can be effectively adapted to assess it against its source document, thereby transforming these metrics into reference-free ones. Experimental results support this hypothesis. After being repurposed reference-freely, the zero-shot BERTScore using the pretrained DeBERTa-large-MNLI model of <0.5B parameters consistently outperforms its original reference-based version across various aspects on the SummEval and Newsroom datasets. It also excels in comparison to most existing reference-free metrics and closely competes with zero-shot summary evaluators based on GPT-3.5.
Open AccessDocAsRef: An Empirical Study on Repurposing Reference-Based Summary Quality Metrics Reference-Freely
Automated summary quality assessment falls into two categories: reference-based and reference-free. Reference-based metrics, historically deemed more accurate due to the additional information provided by human-written references, are limited by their reliance on human input. In this paper, we hypothesize that the comparison methodologies used by some reference-based metrics to evaluate a system summary against its corresponding reference can be effectively adapted to assess it against its source document, thereby transforming these metrics into reference-free ones. Experimental results support this hypothesis. After being repurposed reference-freely, the zero-shot BERTScore using the pretrained DeBERTa-large-MNLI model of <0.5B parameters consistently outperforms its original reference-based version across various aspects on the SummEval and Newsroom datasets. It also excels in comparison to most existing reference-free metrics and closely competes with zero-shot summary evaluators based on GPT-3.5.
- Open Access
IOPathTune: Adaptive Online Parameter Tuning for Parallel File System I/O Path
Parallel file systems contain complicated I/O paths from clients to storage servers. An efficient I/O path requires proper settings of multiple parameters, as the default settings often fail to deliver optimal performance, especially for diverse workloads in the HPC environment. Existing tuning strategies have shortcomings in being adaptive, timely, and flexible. We propose IOPathTune, which adaptively tunes PFS I/O Path online from the client side without characterizing the workloads, doing expensive profiling, and communicating with other machines. We implemented IOPathTune on Lustre and leveraged CloudLab to conduct the evaluations on 20 different Filebench workloads in three different scenarios. We observed either on-par or better performance than the default configuration, as high as 231% on standalone executions. IOPathTune also delivers 89.57% better overall performance than CAPES in multiple client executions.
Open AccessIOPathTune: Adaptive Online Parameter Tuning for Parallel File System I/O Path
Parallel file systems contain complicated I/O paths from clients to storage servers. An efficient I/O path requires proper settings of multiple parameters, as the default settings often fail to deliver optimal performance, especially for diverse workloads in the HPC environment. Existing tuning strategies have shortcomings in being adaptive, timely, and flexible. We propose IOPathTune, which adaptively tunes PFS I/O Path online from the client side without characterizing the workloads, doing expensive profiling, and communicating with other machines. We implemented IOPathTune on Lustre and leveraged CloudLab to conduct the evaluations on 20 different Filebench workloads in three different scenarios. We observed either on-par or better performance than the default configuration, as high as 231% on standalone executions. IOPathTune also delivers 89.57% better overall performance than CAPES in multiple client executions.
- Open Access
- 1 January 2023
- Published by Association for Computational Linguistics (ACL)
- p. 1226-1235
DocAsRef: An Empirical Study on Repurposing Reference-based Summary Quality Metrics as Reference-free Metrics
Forrest Bao, Ruixuan Tu, Ge Luo, Yinfei Yang, Hebi Li, Minghui Qiu, Youbiao He, Cen Chen. Findings of the Association for Computational Linguistics: EMNLP 2023. 2023.
- 1 January 2023
- Published by Association for Computational Linguistics (ACL)
- p. 1226-1235
Open AccessDocAsRef: An Empirical Study on Repurposing Reference-based Summary Quality Metrics as Reference-free Metrics
Forrest Bao, Ruixuan Tu, Ge Luo, Yinfei Yang, Hebi Li, Minghui Qiu, Youbiao He, Cen Chen. Findings of the Association for Computational Linguistics: EMNLP 2023. 2023.
- Open Access
SueNes: A Weakly Supervised Approach to Evaluating Single-Document Summarization via Negative Sampling
Canonical automatic summary evaluation metrics, such as ROUGE, focus on lexical similarity which cannot well capture semantics nor linguistic quality and require a reference summary which is costly to obtain. Recently, there have been a growing number of efforts to alleviate either or both of the two drawbacks. In this paper, we present a proof-of-concept study to a weakly supervised summary evaluation approach without the presence of reference summaries. Massive data in existing summarization datasets are transformed for training by pairing documents with corrupted reference summaries. In cross-domain tests, our strategy outperforms baselines with promising improvements, and show a great advantage in gauging linguistic qualities over all metrics.
Open AccessSueNes: A Weakly Supervised Approach to Evaluating Single-Document Summarization via Negative Sampling
Canonical automatic summary evaluation metrics, such as ROUGE, focus on lexical similarity which cannot well capture semantics nor linguistic quality and require a reference summary which is costly to obtain. Recently, there have been a growing number of efforts to alleviate either or both of the two drawbacks. In this paper, we present a proof-of-concept study to a weakly supervised summary evaluation approach without the presence of reference summaries. Massive data in existing summarization datasets are transformed for training by pairing documents with corrupted reference summaries. In cross-domain tests, our strategy outperforms baselines with promising improvements, and show a great advantage in gauging linguistic qualities over all metrics.
- Open Access
- 7 April 2021
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 23  (4) , e23948
A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation
Background: Effectively and efficiently diagnosing patients who have COVID-19 with the accurate clinical type of the disease is essential to achieve optimal outcomes for the patients as well as to reduce the risk of overloading the health care system. Currently, severe and nonsevere COVID-19 types are differentiated by only a few features, which do not comprehensively characterize the complicated pathological, physiological, and immunological responses to SARS-CoV-2 infection in the different disease types. In addition, these type-defining features may not be readily testable at the time of diagnosis. Objective: In this study, we aimed to use a machine learning approach to understand COVID-19 more comprehensively, accurately differentiate severe and nonsevere COVID-19 clinical types based on multiple medical features, and provide reliable predictions of the clinical type of the disease. Methods: For this study, we recruited 214 confirmed patients with nonsevere COVID-19 and 148 patients with severe COVID-19. The clinical characteristics (26 features) and laboratory test results (26 features) upon admission were acquired as two input modalities. Exploratory analyses demonstrated that these features differed substantially between two clinical types. Machine learning random forest models based on all the features in each modality as well as on the top 5 features in each modality combined were developed and validated to differentiate COVID-19 clinical types. Results: Using clinical and laboratory results independently as input, the random forest models achieved >90% and >95% predictive accuracy, respectively. The importance scores of the input features were further evaluated, and the top 5 features from each modality were identified (age, hypertension, cardiovascular disease, gender, and diabetes for the clinical features modality, and dimerized plasmin fragment D, high sensitivity troponin I, absolute neutrophil count, interleukin 6, and lactate dehydrogenase for the laboratory testing modality, in descending order). Using these top 10 multimodal features as the only input instead of all 52 features combined, the random forest model was able to achieve 97% predictive accuracy. Conclusions: Our findings shed light on how the human body reacts to SARS-CoV-2 infection as a unit and provide insights on effectively evaluating the disease severity of patients with COVID-19 based on more common medical features when gold standard features are not available. We suggest that clinical information can be used as an initial screening tool for self-evaluation and triage, while laboratory test results should be applied when accuracy is the priority.
- 7 April 2021
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 23  (4) , e23948
Open AccessA Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation
Background: Effectively and efficiently diagnosing patients who have COVID-19 with the accurate clinical type of the disease is essential to achieve optimal outcomes for the patients as well as to reduce the risk of overloading the health care system. Currently, severe and nonsevere COVID-19 types are differentiated by only a few features, which do not comprehensively characterize the complicated pathological, physiological, and immunological responses to SARS-CoV-2 infection in the different disease types. In addition, these type-defining features may not be readily testable at the time of diagnosis. Objective: In this study, we aimed to use a machine learning approach to understand COVID-19 more comprehensively, accurately differentiate severe and nonsevere COVID-19 clinical types based on multiple medical features, and provide reliable predictions of the clinical type of the disease. Methods: For this study, we recruited 214 confirmed patients with nonsevere COVID-19 and 148 patients with severe COVID-19. The clinical characteristics (26 features) and laboratory test results (26 features) upon admission were acquired as two input modalities. Exploratory analyses demonstrated that these features differed substantially between two clinical types. Machine learning random forest models based on all the features in each modality as well as on the top 5 features in each modality combined were developed and validated to differentiate COVID-19 clinical types. Results: Using clinical and laboratory results independently as input, the random forest models achieved >90% and >95% predictive accuracy, respectively. The importance scores of the input features were further evaluated, and the top 5 features from each modality were identified (age, hypertension, cardiovascular disease, gender, and diabetes for the clinical features modality, and dimerized plasmin fragment D, high sensitivity troponin I, absolute neutrophil count, interleukin 6, and lactate dehydrogenase for the laboratory testing modality, in descending order). Using these top 10 multimodal features as the only input instead of all 52 features combined, the random forest model was able to achieve 97% predictive accuracy. Conclusions: Our findings shed light on how the human body reacts to SARS-CoV-2 infection as a unit and provide insights on effectively evaluating the disease severity of patients with COVID-19 based on more common medical features when gold standard features are not available. We suggest that clinical information can be used as an initial screening tool for self-evaluation and triage, while laboratory test results should be applied when accuracy is the priority.
- Open Access
- 6 January 2021
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 23  (1) , e25535
Accurately Differentiating Between Patients With COVID-19, Patients With Other Viral Infections, and Healthy Individuals: Multimodal Late Fusion Learning Approach
Background: Effectively identifying patients with COVID-19 using nonpolymerase chain reaction biomedical data is critical for achieving optimal clinical outcomes. Currently, there is a lack of comprehensive understanding in various biomedical features and appropriate analytical approaches for enabling the early detection and effective diagnosis of patients with COVID-19. Objective: We aimed to combine low-dimensional clinical and lab testing data, as well as high-dimensional computed tomography (CT) imaging data, to accurately differentiate between healthy individuals, patients with COVID-19, and patients with non-COVID viral pneumonia, especially at the early stage of infection. Methods: In this study, we recruited 214 patients with nonsevere COVID-19, 148 patients with severe COVID-19, 198 noninfected healthy participants, and 129 patients with non-COVID viral pneumonia. The participants’ clinical information (ie, 23 features), lab testing results (ie, 10 features), and CT scans upon admission were acquired and used as 3 input feature modalities. To enable the late fusion of multimodal features, we constructed a deep learning model to extract a 10-feature high-level representation of CT scans. We then developed 3 machine learning models (ie, k-nearest neighbor, random forest, and support vector machine models) based on the combined 43 features from all 3 modalities to differentiate between the following 4 classes: nonsevere, severe, healthy, and viral pneumonia. Results: Multimodal features provided substantial performance gain from the use of any single feature modality. All 3 machine learning models had high overall prediction accuracy (95.4%-97.7%) and high class-specific prediction accuracy (90.6%-99.9%). Conclusions: Compared to the existing binary classification benchmarks that are often focused on single-feature modality, this study’s hybrid deep learning-machine learning framework provided a novel and effective breakthrough for clinical applications. Our findings, which come from a relatively large sample size, and analytical workflow will supplement and assist with clinical decision support for current COVID-19 diagnostic methods and other clinical applications with high-dimensional multimodal biomedical features.
- 6 January 2021
- Published by JMIR Publications Inc. in Journal of Medical Internet Research
- Vol. 23  (1) , e25535
Open AccessAccurately Differentiating Between Patients With COVID-19, Patients With Other Viral Infections, and Healthy Individuals: Multimodal Late Fusion Learning Approach
Background: Effectively identifying patients with COVID-19 using nonpolymerase chain reaction biomedical data is critical for achieving optimal clinical outcomes. Currently, there is a lack of comprehensive understanding in various biomedical features and appropriate analytical approaches for enabling the early detection and effective diagnosis of patients with COVID-19. Objective: We aimed to combine low-dimensional clinical and lab testing data, as well as high-dimensional computed tomography (CT) imaging data, to accurately differentiate between healthy individuals, patients with COVID-19, and patients with non-COVID viral pneumonia, especially at the early stage of infection. Methods: In this study, we recruited 214 patients with nonsevere COVID-19, 148 patients with severe COVID-19, 198 noninfected healthy participants, and 129 patients with non-COVID viral pneumonia. The participants’ clinical information (ie, 23 features), lab testing results (ie, 10 features), and CT scans upon admission were acquired and used as 3 input feature modalities. To enable the late fusion of multimodal features, we constructed a deep learning model to extract a 10-feature high-level representation of CT scans. We then developed 3 machine learning models (ie, k-nearest neighbor, random forest, and support vector machine models) based on the combined 43 features from all 3 modalities to differentiate between the following 4 classes: nonsevere, severe, healthy, and viral pneumonia. Results: Multimodal features provided substantial performance gain from the use of any single feature modality. All 3 machine learning models had high overall prediction accuracy (95.4%-97.7%) and high class-specific prediction accuracy (90.6%-99.9%). Conclusions: Compared to the existing binary classification benchmarks that are often focused on single-feature modality, this study’s hybrid deep learning-machine learning framework provided a novel and effective breakthrough for clinical applications. Our findings, which come from a relatively large sample size, and analytical workflow will supplement and assist with clinical decision support for current COVID-19 diagnostic methods and other clinical applications with high-dimensional multimodal biomedical features.
- Open Access
- 5 November 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Accurately Differentiating Between Patients With COVID-19, Patients With Other Viral Infections, and Healthy Individuals: Multimodal Late Fusion Learning Approach (Preprint)
BACKGROUND Effectively identifying patients with COVID-19 using nonpolymerase chain reaction biomedical data is critical for achieving optimal clinical outcomes. Currently, there is a lack of comprehensive understanding in various biomedical features and appropriate analytical approaches for enabling the early detection and effective diagnosis of patients with COVID-19. OBJECTIVE We aimed to combine low-dimensional clinical and lab testing data, as well as high-dimensional computed tomography (CT) imaging data, to accurately differentiate between healthy individuals, patients with COVID-19, and patients with non-COVID viral pneumonia, especially at the early stage of infection. METHODS In this study, we recruited 214 patients with nonsevere COVID-19, 148 patients with severe COVID-19, 198 noninfected healthy participants, and 129 patients with non-COVID viral pneumonia. The participants’ clinical information (ie, 23 features), lab testing results (ie, 10 features), and CT scans upon admission were acquired and used as 3 input feature modalities. To enable the late fusion of multimodal features, we constructed a deep learning model to extract a 10-feature high-level representation of CT scans. We then developed 3 machine learning models (ie, k-nearest neighbor, random forest, and support vector machine models) based on the combined 43 features from all 3 modalities to differentiate between the following 4 classes: nonsevere, severe, healthy, and viral pneumonia. RESULTS Multimodal features provided substantial performance gain from the use of any single feature modality. All 3 machine learning models had high overall prediction accuracy (95.4%-97.7%) and high class-specific prediction accuracy (90.6%-99.9%). CONCLUSIONS Compared to the existing binary classification benchmarks that are often focused on single-feature modality, this study’s hybrid deep learning-machine learning framework provided a novel and effective breakthrough for clinical applications. Our findings, which come from a relatively large sample size, and analytical workflow will supplement and assist with clinical decision support for current COVID-19 diagnostic methods and other clinical applications with high-dimensional multimodal biomedical features.
- 5 November 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessAccurately Differentiating Between Patients With COVID-19, Patients With Other Viral Infections, and Healthy Individuals: Multimodal Late Fusion Learning Approach (Preprint)
BACKGROUND Effectively identifying patients with COVID-19 using nonpolymerase chain reaction biomedical data is critical for achieving optimal clinical outcomes. Currently, there is a lack of comprehensive understanding in various biomedical features and appropriate analytical approaches for enabling the early detection and effective diagnosis of patients with COVID-19. OBJECTIVE We aimed to combine low-dimensional clinical and lab testing data, as well as high-dimensional computed tomography (CT) imaging data, to accurately differentiate between healthy individuals, patients with COVID-19, and patients with non-COVID viral pneumonia, especially at the early stage of infection. METHODS In this study, we recruited 214 patients with nonsevere COVID-19, 148 patients with severe COVID-19, 198 noninfected healthy participants, and 129 patients with non-COVID viral pneumonia. The participants’ clinical information (ie, 23 features), lab testing results (ie, 10 features), and CT scans upon admission were acquired and used as 3 input feature modalities. To enable the late fusion of multimodal features, we constructed a deep learning model to extract a 10-feature high-level representation of CT scans. We then developed 3 machine learning models (ie, k-nearest neighbor, random forest, and support vector machine models) based on the combined 43 features from all 3 modalities to differentiate between the following 4 classes: nonsevere, severe, healthy, and viral pneumonia. RESULTS Multimodal features provided substantial performance gain from the use of any single feature modality. All 3 machine learning models had high overall prediction accuracy (95.4%-97.7%) and high class-specific prediction accuracy (90.6%-99.9%). CONCLUSIONS Compared to the existing binary classification benchmarks that are often focused on single-feature modality, this study’s hybrid deep learning-machine learning framework provided a novel and effective breakthrough for clinical applications. Our findings, which come from a relatively large sample size, and analytical workflow will supplement and assist with clinical decision support for current COVID-19 diagnostic methods and other clinical applications with high-dimensional multimodal biomedical features.
- Open Access
- 30 August 2020
- Published by JMIR Publications Inc. in JMIR Preprints
A Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation (Preprint)
BACKGROUND Effectively and efficiently diagnosing patients who have COVID-19 with the accurate clinical type of the disease is essential to achieve optimal outcomes for the patients as well as to reduce the risk of overloading the health care system. Currently, severe and nonsevere COVID-19 types are differentiated by only a few features, which do not comprehensively characterize the complicated pathological, physiological, and immunological responses to SARS-CoV-2 infection in the different disease types. In addition, these type-defining features may not be readily testable at the time of diagnosis. OBJECTIVE In this study, we aimed to use a machine learning approach to understand COVID-19 more comprehensively, accurately differentiate severe and nonsevere COVID-19 clinical types based on multiple medical features, and provide reliable predictions of the clinical type of the disease. METHODS For this study, we recruited 214 confirmed patients with nonsevere COVID-19 and 148 patients with severe COVID-19. The clinical characteristics (26 features) and laboratory test results (26 features) upon admission were acquired as two input modalities. Exploratory analyses demonstrated that these features differed substantially between two clinical types. Machine learning random forest models based on all the features in each modality as well as on the top 5 features in each modality combined were developed and validated to differentiate COVID-19 clinical types. RESULTS Using clinical and laboratory results independently as input, the random forest models achieved >90% and >95% predictive accuracy, respectively. The importance scores of the input features were further evaluated, and the top 5 features from each modality were identified (age, hypertension, cardiovascular disease, gender, and diabetes for the clinical features modality, and dimerized plasmin fragment D, high sensitivity troponin I, absolute neutrophil count, interleukin 6, and lactate dehydrogenase for the laboratory testing modality, in descending order). Using these top 10 multimodal features as the only input instead of all 52 features combined, the random forest model was able to achieve 97% predictive accuracy. CONCLUSIONS Our findings shed light on how the human body reacts to SARS-CoV-2 infection as a unit and provide insights on effectively evaluating the disease severity of patients with COVID-19 based on more common medical features when gold standard features are not available. We suggest that clinical information can be used as an initial screening tool for self-evaluation and triage, while laboratory test results should be applied when accuracy is the priority.
- 30 August 2020
- Published by JMIR Publications Inc. in JMIR Preprints
Open AccessA Multimodality Machine Learning Approach to Differentiate Severe and Nonsevere COVID-19: Model Development and Validation (Preprint)
BACKGROUND Effectively and efficiently diagnosing patients who have COVID-19 with the accurate clinical type of the disease is essential to achieve optimal outcomes for the patients as well as to reduce the risk of overloading the health care system. Currently, severe and nonsevere COVID-19 types are differentiated by only a few features, which do not comprehensively characterize the complicated pathological, physiological, and immunological responses to SARS-CoV-2 infection in the different disease types. In addition, these type-defining features may not be readily testable at the time of diagnosis. OBJECTIVE In this study, we aimed to use a machine learning approach to understand COVID-19 more comprehensively, accurately differentiate severe and nonsevere COVID-19 clinical types based on multiple medical features, and provide reliable predictions of the clinical type of the disease. METHODS For this study, we recruited 214 confirmed patients with nonsevere COVID-19 and 148 patients with severe COVID-19. The clinical characteristics (26 features) and laboratory test results (26 features) upon admission were acquired as two input modalities. Exploratory analyses demonstrated that these features differed substantially between two clinical types. Machine learning random forest models based on all the features in each modality as well as on the top 5 features in each modality combined were developed and validated to differentiate COVID-19 clinical types. RESULTS Using clinical and laboratory results independently as input, the random forest models achieved >90% and >95% predictive accuracy, respectively. The importance scores of the input features were further evaluated, and the top 5 features from each modality were identified (age, hypertension, cardiovascular disease, gender, and diabetes for the clinical features modality, and dimerized plasmin fragment D, high sensitivity troponin I, absolute neutrophil count, interleukin 6, and lactate dehydrogenase for the laboratory testing modality, in descending order). Using these top 10 multimodal features as the only input instead of all 52 features combined, the random forest model was able to achieve 97% predictive accuracy. CONCLUSIONS Our findings shed light on how the human body reacts to SARS-CoV-2 infection as a unit and provide insights on effectively evaluating the disease severity of patients with COVID-19 based on more common medical features when gold standard features are not available. We suggest that clinical information can be used as an initial screening tool for self-evaluation and triage, while laboratory test results should be applied when accuracy is the priority.